Why Relay Therapeutics Stock Popped This Wednesday
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,201 articlesA dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
The House approved a veterans benefits expansion funded by higher VA refinance fees, prompting a national debate over...
AI's rise depends not only on chips and servers but on the cooling and mechanical systems that keep data centers aliv...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Texas’ GOP Senate runoff pits Sen. John Cornyn against Ken Paxton as Trump weighs in, boosting a race already fueled ...
The AI rally around optics stocks like Lumentum has turned heads. But a single red flag can derail gains. This guide ...
Former President Donald Trump publicly supports CFTC Chair Michael Selig's push to widen federal control over predict...
Solana is showing real on-chain activity even as its price remains subdued. Upgrades and major payments partnerships ...
Ripple’s On-Demand Liquidity uses XRP to settle cross-border payments in seconds, cutting pre-funding needs and boost...
Exxon's decision to redomicile to Texas sets off a broader dialog on governance. The texas stock exchange ceo argues ...